{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alzheimer%C2%B4s+Disease", "query": { "condition": "Alzheimer´s Disease" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 46, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alzheimer%C2%B4s+Disease&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T03:40:24.996Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07155980", "title": "A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult Participants" ], "interventions": [ { "name": "GSM-779690T", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Acta Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "20 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2025-11-09", "completion_date": "2026-07-11", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07155980" }, { "nct_id": "NCT04777409", "title": "A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Alzheimer´s Disease" ], "interventions": [ { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo (semaglutide)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 1840, "start_date": "2021-05-18", "completion_date": "2026-01-30", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 107, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 85 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04777409" }, { "nct_id": "NCT07429591", "title": "Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Caregivers of Alzheimer's Disease or Memory Problem Patients", "Caregiver Wellbeing", "Elder Abuse" ], "interventions": [ { "name": "Risk Assessment Screening", "type": "BEHAVIORAL" }, { "name": "Coach and Website Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2026-05-01", "completion_date": "2027-08-30", "has_results": false, "last_update_posted_date": "2026-02-24", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07429591" }, { "nct_id": "NCT07187141", "title": "Nasal Protollin in Early Symptomatic Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease (AD)" ], "interventions": [ { "name": "Protollin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2021-11-18", "completion_date": "2023-02-21", "has_results": false, "last_update_posted_date": "2025-09-22", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07187141" }, { "nct_id": "NCT02226835", "title": "Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age-Related Macular Degeneration", "Alzheiner's Disease", "AMD" ], "interventions": [], "intervention_types": [], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 33, "start_date": "2014-08-13", "completion_date": "2017-01-24", "has_results": false, "last_update_posted_date": "2018-09-27", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02226835" }, { "nct_id": "NCT07142278", "title": "DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease", "Alzheimer Disease (AD)", "Preclinical Alzheimer's Disease" ], "interventions": [ { "name": "DUVAX 200 µg", "type": "BIOLOGICAL" }, { "name": "DUVAX 400 µg", "type": "BIOLOGICAL" }, { "name": "Placebo (Adjuvant only)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Nuravax, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "40 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2025-11-01", "completion_date": "2027-07-31", "has_results": false, "last_update_posted_date": "2025-10-22", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 1, "location_summary": "Miami Lakes, Florida", "locations": [ { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07142278" }, { "nct_id": "NCT07182357", "title": "Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease and Related Dementias" ], "interventions": [ { "name": "Dementia Care Management Checklist for Hospice Transitions", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "New York University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2025-10", "completion_date": "2028-07-31", "has_results": false, "last_update_posted_date": "2025-09-19", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07182357" }, { "nct_id": "NCT01524887", "title": "Phase 3 IGIV, 10% in Alzheimer´s Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer´s Disease" ], "interventions": [ { "name": "Immune Globulin Intravenous (Human), 10% Solution", "type": "BIOLOGICAL" }, { "name": "Human albumin 0.25%", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "50 Years to 89 Years" }, "enrollment_count": 508, "start_date": "2012-01-23", "completion_date": "2013-07-16", "has_results": true, "last_update_posted_date": "2021-05-19", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 37, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Long Beach, California + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01524887" }, { "nct_id": "NCT04777396", "title": "A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Alzheimer's Disease" ], "interventions": [ { "name": "Semagludtide", "type": "DRUG" }, { "name": "Placebo (semaglutide)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 1840, "start_date": "2021-05-18", "completion_date": "2026-01-30", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 96, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 76 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04777396" }, { "nct_id": "NCT01230853", "title": "A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Active Comparator: A", "type": "DRUG" }, { "name": "Placebo Comparator B", "type": "DRUG" }, { "name": "Active Comparator B", "type": "DRUG" }, { "name": "Placebo Comparator A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 80, "start_date": "2010-08", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2020-11-23", "last_synced_at": "2026-06-10T03:40:24.996Z", "location_count": 8, "location_summary": "Garden Grove, California • San Francisco, California • Orlando, Florida + 5 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01230853" } ] }